Hypoglycemia following the use of glucagon-like peptide-1 receptor agonists: a real-world analysis of post-marketing surveillance data

BACKGROUND: Recent evidence has emerged concerning hypoglycemia following the application of glucagon-like peptide-1 receptor agonists (GLP-1RAs). Nevertheless, few real-world investigations have been performed to determine the clinical characteristics, onset, and outcomes of hypoglycemia associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhe, Tang, Yan, Hu, Yang, Zhu, Huijuan, Chen, Xiaoguang, Zhao, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506728/
https://www.ncbi.nlm.nih.gov/pubmed/34734034
http://dx.doi.org/10.21037/atm-21-4162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506728/
https://www.ncbi.nlm.nih.gov/pubmed/34734034
http://dx.doi.org/10.21037/atm-21-4162

Ejemplares similares